Idiopathic Thrombocytopenic Purpura (ITP)
What is ITP?
Immune thrombocytopenic purpura (ITP) is an autoimmune disease in which your body attacks its own platelets – small cells in your blood that that help to build a clot to stop bleeding.
People with ITP often experience purple bruises and red or purple skin discolorations, as well as nosebleeds, bleeding of the gums, heavy menstrual bleeding, and hematomas. CSL Behring offers immunoglobulin therapies to increase a patient’s platelet counts.
Resources for you
| Product Websites | Privigen.com (United States) Rhophylac.co.uk (United Kingdom) Rhophylac.com (United States) |
Treatments Available
Availability of treatments may vary from country to country. Please be sure to visit your local CSLBehring.com site for further information.
| Privigen® | Immune Globulin Intravenous (Human) 10% Liquid | Visit Website | |
| Carimune® NF / Sandoglobulin® / Redimune® / Sanglopor® | Immune Globulin Intravenous (Human) | Visit Website | |
| Rhophylac® | Rho(D) Immune Globulin Intravenous (Human) | Visit Website |
Participate in Clinical Trials
Discover what is involved in participating in one of our clinical trials and how you can enroll.
Learn MoreGet our latest Vita stories in your inbox
Thanks!
You have now been added
to the CSL Behring Vita list